Nuria B. V.
- Country
- Spain
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 11 of 11 partner sites.
Specializations
Hematologic malignancies
Clinical research activity is centered on acute myeloid leukemia, myelodysplastic syndromes, myelofibrosis, multiple myeloma, and lymphoid neoplasms, with attention to relapsed, refractory, and newly diagnosed disease settings.
- Acute leukemia
- Myelodysplastic syndromes
- Myelofibrosis
- Multiple myeloma
- Diffuse large B-cell lymphoma
Therapeutic interests include targeted agents, immunotherapy, and novel combination regimens in hematology.
Breast cancer
The investigator is strongly involved in studies of early breast cancer, locally advanced disease, and metastatic breast cancer, spanning HER2-positive, HER2-negative, hormone receptor-positive, and triple-negative breast cancer subtypes.
- HER2-positive breast cancer
- Hormone receptor-positive breast cancer
- Metastatic breast cancer
- Triple-negative breast cancer
- PIK3CA-mutated breast cancer
Key therapeutic themes include endocrine therapy, CDK4/6 inhibition, antibody-drug conjugates, and adjuvant treatment.
Solid tumors and genitourinary oncology
Research involvement also extends to renal cell carcinoma, urothelial carcinoma, bladder cancer, prostate cancer, ovarian cancer, pancreatic adenocarcinoma, and non-small-cell lung cancer.
- Renal cell carcinoma
- Prostate cancer
- Ovarian cancer
- Bladder cancer
- Pancreatic adenocarcinoma
Therapeutic focus includes perioperative oncology, maintenance treatment, and molecularly guided therapy.
Immune and rare hematologic disorders
Additional interest is seen in paroxysmal nocturnal hemoglobinuria, immune thrombocytopenia, autoinflammatory diseases, and complement-mediated disorders, reflecting a broader engagement with immune dysregulation and rare disease therapeutics.
- Paroxysmal nocturnal hemoglobinuria
- Immune thrombocytopenia
- Autoinflammatory disease
- Complement inhibition
- Rare hematologic disorders
This area includes interest in immune-modulating therapies and precision approaches for uncommon blood disorders.
Cardiovascular and pulmonary disease
The clinical portfolio also includes atherosclerotic cardiovascular disease, coronary artery disease, calcific aortic valve stenosis, dilated cardiomyopathy, and chronic obstructive pulmonary disease.
- Atherosclerotic cardiovascular disease
- Calcific aortic valve stenosis
- Dilated cardiomyopathy
- Coronary artery disease
- Chronic obstructive pulmonary disease
Therapeutic interests cover cardiovascular prevention, valvular disease, and respiratory symptom control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.